Abbott Labs to sell part of generics business for $5.3 billion

Abbott Laboratories sells its developed markets branded generics pharmaceuticals business to Mylan in a $5.3 billion deal that includes the formation of a new publicly traded company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.